Adding IL-2 to Tebentafusp to Eradicate Cancer Progression

Clinical trial NCT07063875 · RECRUITING

Trial details

NCT number: NCT07063875
Sponsor: St Vincent's Hospital, Sydney
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Uveal Melanoma Metastatic Uveal Melanoma Metastatic Uveal Melanoma in the Liver

Start date: 2025-06-01
Primary completion: 2027-09-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.